Plain-English translation of NCT05552222 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether two new medications called and —each paired with existing cancer drugs—can help people with newly diagnosed multiple myeloma live longer and feel better than the current standard treatment. Multiple myeloma is a type of blood cancer, and this trial compares three different drug combinations to see which works best for patients who are not eligible for or not planning to have stem cell transplant as their first treatment.
Multiple myeloma is a serious blood cancer, and while there are treatments available, doctors are constantly looking for ways to help patients live longer and with fewer side effects. This medication represents a new approach that may be more effective than current treatments for certain patients.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of three groups, each receiving a different combination of injected medications and pills. You'll visit the clinic regularly for blood tests, checkups, and to receive your treatment. The study will continue until the doctors determine whether one treatment is clearly better than the others, which may take months or longer. Throughout your participation, you'll be closely monitored for how well the treatment is working and any side effects you may experience.
AI-generated summary from trial data · Oct 4, 2026 · Not medical advice
United States